We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00512811
First Posted: August 8, 2007
Last Update Posted: August 8, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Baqiyatallah Medical Sciences University
  Purpose
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Condition Intervention Phase
Bronchiolitis Drug: furosemide Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Resource links provided by NLM:


Further study details as provided by Baqiyatallah Medical Sciences University:

Primary Outcome Measures:
  • effect of furosemid inhalation on dyspnea

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   32 Years to 83 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512811


Locations
Iran, Islamic Republic of
RCCI
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Investigators
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
  More Information

ClinicalTrials.gov Identifier: NCT00512811     History of Changes
Other Study ID Numbers: 121a25
First Submitted: August 7, 2007
First Posted: August 8, 2007
Last Update Posted: August 8, 2007
Last Verified: August 2007

Keywords provided by Baqiyatallah Medical Sciences University:
furosemide
inhalation
dyspnea
spirometry
mustard gas
bronchiolitis
sulfur mustard

Additional relevant MeSH terms:
Respiratory Aspiration
Bronchiolitis
Dyspnea
Respiration Disorders
Respiratory Tract Diseases
Pathologic Processes
Bronchitis
Bronchial Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections
Signs and Symptoms, Respiratory
Signs and Symptoms
Furosemide
Mechlorethamine
Mustard Gas
Diuretics
Natriuretic Agents
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Alkylating Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents
Dermatologic Agents